/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

WEREWOLF THERAPEUTICS INC Share Price Today: Live Updates & Key Insights

WEREWOLF THERAPEUTICS INC share price today is $0.7772, up -2.97%. The stock opened at $0.804 against the previous close of $0.8101, with an intraday high of $0.804 and low of $0.77.

WEREWOLF THERAPEUTICS INC Share Price Chart

style
pb-0

WEREWOLF THERAPEUTICS INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

WEREWOLF THERAPEUTICS INC Share Price Performance

$0.7772 -0.0297(-2.97%) HOWL at 23 Mar 2026 01:29 PM Biotechnology
Lowest Today 0.77
Highest Today 0.804
Today’s Open 0.804
Prev. Close 0.8101
52 Week High 2.38
52 Week Low 0.53
Day’s Range: Low 0.77 High 0.804
52-Week Range: Low 0.53 High 2.38
1 day return -
1 Week return -2.99
1 month return +22.02
3 month return +17.11
6 month return -57.28
1 year return -29.9
3 year return -65.86
5 year return -95.11
10 year return -

WEREWOLF THERAPEUTICS INC Institutional Holdings

RA Capital Management, LLC 13.76

Mpm Asset Management, LLC 8.88

MPM Oncology Impact Management LP 4.96

Bank of America Corp 3.77

Vanguard Group Inc 2.90

Vanguard Total Stock Mkt Idx Inv 1.80

Renaissance Technologies Corp 1.40

Sphera Funds Management Ltd. 1.29

DC Funds, LP 1.21

Partner Fund Management LP 0.83

Vanguard Institutional Extnd Mkt Idx Tr 0.71

Geode Capital Management, LLC 0.69

Millennium Management LLC 0.49

Alyeska Investment Group, L.P. 0.49

Vifag 2002 SICAV 0.45

Fidelity Extended Market Index 0.35

Jane Street Group LLC 0.32

State Street Corp 0.25

BlackRock Inc 0.21

Susquehanna International Group, LLP 0.21

Abante Quant Value FI 0.18

Bridgeway Capital Management, LLC 0.16

Bridgeway Ultra-Small Company Market 0.15

Northern Trust Corp 0.14

Blackrock Extended Mkt Fund CF 0.13

NT Ext Equity Mkt Idx Fd - L 0.13

The Goldman Sachs Group Inc 0.12

Vontobel Holding Ltd. 0.12

Extended Equity Market Fund K 0.11

Fidelity Total Market Index 0.11

Fidelity Series Total Market Index 0.09

Northern Trust Extended Eq Market Idx 0.08

Spartan Extended Market Index Pool F 0.08

NT Ext Equity Mkt Idx Fd - NL 0.05

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.05

Spartan Total Market Index Pool G 0.05

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

Fidelity Nasdaq Composite Index 0.03

Vanguard U.S. Eq Idx £ Acc 0.02

WEREWOLF THERAPEUTICS INC Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

WEREWOLF THERAPEUTICS INC Fundamentals

Market Cap 38.15 M

PB Ratio 1.2918

PE Ratio 0.0

Enterprise Value 9.84 M

Total Assets 126.93 M

Volume 207752

WEREWOLF THERAPEUTICS INC Company Financials

Annual Revenue FY23:25725000 25.7M, FY22:16401000 16.4M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:16401000 16.4M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-37295000 -37.3M, FY22:-51564000 -51.6M, FY21:-49767000 -49.8M, FY20:-14939000 -14.9M, FY19:-10990000 -11.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:1143000 1.1M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-406000 -0.4M, Q1/2025:-426000 -0.4M, Q3/2024:null 0.0M, Q2/2024:689000 0.7M

Quarterly Net worth Q3/2025:-16370000 -16.4M, Q2/2025:-17982000 -18.0M, Q1/2025:-18089000 -18.1M, Q3/2024:-16673000 -16.7M, Q2/2024:-17249000 -17.2M

About WEREWOLF THERAPEUTICS INC & investment objective

Company Information Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.

Organisation Biotechnology

Employees 39

Industry Biotechnology

CEO Dr. Daniel J. Hicklin Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

WEREWOLF THERAPEUTICS INC FAQs

What is the share price of WEREWOLF THERAPEUTICS INC today?

The current share price of WEREWOLF THERAPEUTICS INC is $0.7772.

Can I buy WEREWOLF THERAPEUTICS INC shares in India?

Yes, Indian investors can buy WEREWOLF THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy WEREWOLF THERAPEUTICS INC shares in India?

You can easily invest in WEREWOLF THERAPEUTICS INC shares from India by:

Can I buy fractional shares of WEREWOLF THERAPEUTICS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of WEREWOLF THERAPEUTICS INC?

WEREWOLF THERAPEUTICS INC has a market cap of $38.15 M.

In which sector does WEREWOLF THERAPEUTICS INC belong?

WEREWOLF THERAPEUTICS INC operates in the Biotechnology sector.

What documents are required to invest in WEREWOLF THERAPEUTICS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of WEREWOLF THERAPEUTICS INC?

The PE ratio of WEREWOLF THERAPEUTICS INC is N/A and the PB ratio is 1.29.